US 10233452
Compositions and methods for increasing erythropoietin (EPO) production
granted A61KA61K31/713
Quick answer
US patent 10233452 (Compositions and methods for increasing erythropoietin (EPO) production) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/713